HomeCompareVBLT vs YUM

VBLT vs YUM: Dividend Comparison 2026

VBLT yields 1282.05% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VBLT wins by $169777724.31M in total portfolio value
10 years
VBLT
VBLT
● Live price
1282.05%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$169777724.42M
Annual income
$147,192,786,254,209.56
Full VBLT calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — VBLT vs YUM

📍 VBLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVBLTYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VBLT + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VBLT pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBLT
Annual income on $10K today (after 15% tax)
$108,974.36/yr
After 10yr DRIP, annual income (after tax)
$125,113,868,316,078.12/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, VBLT beats the other by $125,113,868,282,114.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBLT + YUM for your $10,000?

VBLT: 50%YUM: 50%
100% YUM50/50100% VBLT
Portfolio after 10yr
$84888862.26M
Annual income
$73,596,393,147,083.44/yr
Blended yield
86.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

VBLT
Analyst Ratings
6
Buy
2
Hold
Consensus: Buy
Price Target
$5.00
+3105.1% upside vs current
Range: $5.00 — $5.00
Altman Z
-19.9
Piotroski
0/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBLT buys
0
YUM buys
0
No recent congressional trades found for VBLT or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVBLTYUM
Forward yield1282.05%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$169777724.42M$107.0K
Annual income after 10y$147,192,786,254,209.56$39,957.33
Total dividends collected$168105692.30M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold
Analyst price target$5.00$173.15

Year-by-year: VBLT vs YUM ($10,000, DRIP)

YearVBLT PortfolioVBLT Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$138,905$128,205.13$10,980$280.44+$127.9KVBLT
2$1,812,960$1,664,331.75$12,185$435.72+$1.80MVBLT
3$22,241,274$20,301,406.25$13,722$684.14+$22.23MVBLT
4$256,561,041$232,762,878.32$15,773$1,090.14+$256.55MVBLT
5$2,783,868,903$2,509,348,588.72$18,650$1,773.02+$2783.85MVBLT
6$28,425,663,485$25,446,923,758.80$22,921$2,966.37+$28425.64MVBLT
7$273,251,611,466$242,836,151,537.34$29,685$5,158.69+$273251.58MVBLT
8$2,474,012,179,526$2,181,632,955,256.89$41,216$9,453.02+$2474012.14MVBLT
9$21,107,418,843,486$18,460,225,811,393.34$62,672$18,571.31+$21107418.78MVBLT
10$169,777,724,416,739$147,192,786,254,209.56$107,016$39,957.33+$169777724.31MVBLT

VBLT vs YUM: Complete Analysis 2026

VBLTStock

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.

Full VBLT Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this VBLT vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBLT vs SCHDVBLT vs JEPIVBLT vs OVBLT vs KOVBLT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.